Skip to main content

Main navigation

Professor Christian Agyare Named Academic Pharmacist of the Year at Inaugural Pharma Excellence Awards

Professor Christian Agyare Named Academic Pharmacist of the Year at Inaugural Pharma Excellence Awards

Mon 14 Apr 2025 CHS News
Professor Christian Agyare Named Academic Pharmacist of the Year at Inaugural Pharma Excellence Awards i

In a celebration of academic distinction and service to science and society, Professor Christian Agyare has been awarded the Academic Pharmacist of the Year at the Maiden Pharma Excellence Awards organized by the Pharmaceutical Society of Ghana (PSGH). The award acknowledges his exceptional influence in pharmaceutical education, biomedical research, health policy, and mentorship over the past two decades.

Professor Agyare is a globally recognized Professor of Pharmaceutical Microbiology and Natural Products at the Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology (KNUST). He currently serves as Provost of the College of Health Sciences at KNUST, where he provides academic and administrative leadership across one of the most respected health education institutions in West Africa. His scholarly footprint is vast. With over 150 peer-reviewed publications, 14 books and book chapters, and more than 4,300 academic citations, he is ranked among the top researchers both at KNUST and nationally and as a thought leader in pharmaceutical sciences.

Born in Koneyaw, in the Asante-Bekwai Municipality of Ghana’s Ashanti Region, Professor Agyare is the fourth and youngest child of his parents. He began his academic journey at Armed Forces Basic Schools, Kumasi, before progressing to Prempeh College. He earned his Bachelor of Pharmacy (BPharm) and Master of Pharmacy (MPharm) degrees at KNUST. He later received a Dr. rer. nat. (doctoral degree in natural sciences) from the University of Muenster, Germany, on a DAAD scholarship, followed by postdoctoral research at the University of California, San Francisco, and the Novartis Institute for Biomedical Research, Boston.

Read More...